Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis - Related Studies

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

This study has been completed.

Study NCT00121381. Last updated on January 10, 2008. Information provided by Novartis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Dermatitis, Atopic

2	Additional conditions recognized in this trial
		Dermatitis

3	More general conditions related to this trial
		Genetic Diseases, Inborn
		Hypersensitivity
		Hypersensitivity, Immediate
		Immune System Diseases
		Skin Diseases
		Skin Diseases, Eczematous
		Skin Diseases, Genetic

4	Additional drug interventions recognized in this trial
		Pimecrolimus
		Tacrolimus

5	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antirheumatic Agents
		Central Nervous System Agents
		Dermatologic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		Novartis